Veolia vs Stericycle vs MedXwaste Medical Haul Comparison
Why this matters
A junk-removal crew called to clear a closed dental office, a home-care decedent estate, or a vet clinic remodel walks straight into Regulated Medical Waste (RMW) territory the moment a single sharps container, blood-soaked gauze, or unspent vial appears in the pile. RMW is not municipal solid waste; transport without a registered medical waste transporter triggers state DOH fines, OSHA 29 CFR 1910.1030 bloodborne pathogen exposure liability, and DOT 49 CFR 172 hazardous materials violations that scale per shipment. The three national-scale haulers most often quoted to small operators for a one-time clean-out are Veolia North America (formerly Stericycle Environmental Solutions in some markets), Stericycle Inc. (the dominant pure-play RMW hauler in the US), and MedXwaste (regional Northeast and Mid-Atlantic operator with on-demand pickup positioning). The wrong choice on a single-job basis can leave a generator without a signed manifest, void the cleanout insurance rider, and shift cradle-to-grave liability under RCRA Subtitle C onto the junk-removal company that brokered the haul.
Decision criteria
Four variables drive the vendor selection on a one-off cleanout: minimum service window, manifest delivery speed, waste-stream coverage (pathological, chemo trace, pharmaceutical, sharps-only), and whether the facility is a registered generator with an EPA ID. Stericycle's contract model favors recurring small-quantity generators with weekly or 28-day stops; MedXwaste is built for on-demand single hauls with under-72-hour response in covered metros; Veolia handles the broadest waste-stream list including bulk pharmaceutical destruction and trace chemo but requires an account setup that often runs 5-10 business days. If the cleanout is a one-shot estate or office liquidation with no recurring future need, an on-demand model wins on speed; if the customer is a continuing medical practice that the junk-removal company is bridging until a long-term contract is signed, recurring service is cleaner.
Manifest and chain of custody
Every RMW shipment requires a hauler-signed manifest under most state DOH rules, modeled on the RCRA hazardous waste manifest framework at 40 CFR 262 Subpart B. The manifest must travel with the load and a copy returns to the generator within state-specified windows (NY 35 days, NJ 30 days, CA 35 days under California Medical Waste Management Act). Stericycle delivers manifests through its MyStericycle portal within 24-48 hours of destruction. Veolia delivers via the eTrack portal with a similar window. MedXwaste delivers paper copies plus PDF email typically within 5 business days. For a junk-removal company brokering the haul, the manifest is the only proof that liability transferred; absence of a returned manifest within the state window means the generator (and by extension the broker who chose the hauler) remains on the hook for the waste's eventual fate.
Waste-stream coverage matrix
Veolia accepts the broadest list: pathological (Type 3), trace chemo (Type 4 under most state schemes), bulk chemo, non-hazardous pharmaceutical, hazardous pharmaceutical under RCRA P-listed and U-listed wastes (40 CFR 261.33), sharps, and pathological tissue. Stericycle accepts sharps, red-bag biohazard, pathological, trace chemo, and non-hazardous pharma; bulk RCRA pharma routes to a sister Stericycle Environmental Solutions service line with separate contracting. MedXwaste accepts sharps, red-bag, and pathological; for any chemo trace or RCRA-regulated pharma the operator routes to a partner hauler, which adds a handoff in the chain of custody. For a cleanout containing only sharps and red-bag, all three are technically eligible; once a labeled chemo vial or an unspent CII narcotic appears, the choice narrows to Veolia or a DEA-registered reverse distributor under 21 CFR 1317.
DEA controlled substances exception
Controlled substances (Schedules II-V) are explicitly excluded from medical waste manifest streams. The Secure and Responsible Drug Disposal Act of 2010 (Public Law 111-273) and the DEA implementing rule at 21 CFR 1317 require that CII-CV substances move to a DEA-registered reverse distributor, not an RMW hauler. None of the three haulers above accept CII-CV pharmaceuticals on a standard medical waste manifest. On a decedent or closed-practice cleanout where CII narcotics are present, the junk-removal company must pause, secure the substances per the practice's existing DEA registration (or law enforcement custody if no registrant remains), and route to a separate reverse distributor pickup. Mixing CII into an RMW shipment is a federal violation regardless of which hauler is used.
Documentation the broker must keep
The junk-removal company brokering the haul retains: the original signed manifest (or a copy), the hauler's registration certificate for the operating state, the hauler's DOT HM-181 registration and 49 CFR 172.704 hazmat training documentation, the certificate of destruction once treatment is complete, and the customer-signed RMW acknowledgment that the broker did not weigh or open the regulated containers. These five documents form the audit defense if a state DOH inspector later traces an improperly disposed sharp or vial back through the manifest chain. Retention period is typically 3 years from manifest signing under state DOH rules; OSHA 29 CFR 1910.1030 record retention for exposure documentation runs 30 years for affected workers, a separate clock from the manifest retention.
Brokering medical waste without a transporter license is itself a violation in most states even if the actual haul is performed by a licensed vendor. Verify state-specific broker rules before quoting the customer; some states (CA, NY, NJ) require a broker registration separate from the hauler's transporter permit. The junk-removal crew loading the truck is a transporter under most state definitions.
When to walk away
If the cleanout contains unmarked vials of unknown contents, bulk liquid pharmaceutical waste of unknown formulation, or untreated pathological waste (tissue, organs, identifiable body parts) without a chain of custody from the originating practice, the prudent move is to refuse the line item and refer the customer to a hazardous waste characterization service. Lab-pack characterization under 40 CFR 261.20 takes 5-10 business days and runs into four-figure costs that are not within the typical junk-removal scope. Absorbing this work without proper waste profiling exposes the company to RCRA cradle-to-grave liability that extends decades.
References
- 40 CFR 261-262 (RCRA Subtitle C generator and transporter standards)
- 40 CFR 262 Subpart B (Manifest requirements)
- 40 CFR 261.33 (P-listed and U-listed pharmaceutical wastes)
- 21 CFR 1317 (DEA Secure and Responsible Drug Disposal final rule)
- 49 CFR 172 (DOT Hazardous Materials Regulations)
- OSHA 29 CFR 1910.1030 (Bloodborne Pathogens Standard)
- California Medical Waste Management Act, Health & Safety Code Div 104 Part 14
- New York State Public Health Law Article 13 Title XV
- Public Law 111-273 (Secure and Responsible Drug Disposal Act of 2010)